M Holdings Securities, Inc. Palatin Technologies Inc Transaction History

M Holdings Securities, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 17, 2018	SELL	$0.91 - $1.45 $11,182 - $17,819	-12,289 Closed	0 $0
Q1 2018 May 18, 2018	BUY	$0.84 - $1.18 $889 - $1,249	1,059 Added 9.43%	12,289 $13,000
Q4 2017 Feb 15, 2018	BUY	$0.68 - $1.0 $7,636 - $11,230	11,230	11,230 $950,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.73M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.